The US FDA has approved AstraZeneca’s Tagrisso and chemotherapy combination
AstraZeneca’s combination of AstraZeneca’s blockbuster cancer drug Tagrisso with chemotherapy to treat a type of lung cancer has been approved by the US Food and Drug Administration.
POPULAR POSTS
Trump opts for personal ties to choose his government team
November 15, 2024
UK sets new climate target for 2035
November 13, 2024
Children go back to school after Valencia floods
November 13, 2024
Researchers document huge decline in African elephants
November 13, 2024
LIVE STREAM